Our guest is Dr. Kristen Scarpato, a urologic oncologist at Vanderbilt University Medical Center in Nashville, TN. She is here to talk with us about Androgen Deprivation Therapy, or ADT, for prostate cancer. She covers information such as what is ADT, questions to ask your doctor and what to expect after treatment.

Short on time? Use the below timestamps to jump to any topic section:0:48 - Introduction2:10 - Prostate cancer overview3:30 - What is Androgren Deprivation Therapy (ADT)?4:30 - Why is ADT important?6:43 - When during treatment would ADT be considered?9:32 - What patients benefit the most from ADT?10:45 - What administers ADT?12:10 - What can patients expect after ADT?15:30 - Talking with your doctor17:16 - Final thoughts

Supported by an independent educational grant provided by Myovant Sciences LTD and Pfizer Inc.

For more information, please visit www.UrologyHealth.org and don’t forget to subscribe to our free digital magazine, UrologyHealth extra® at https://www.urologyhealth.org/healthy-living/urologyhealth-extra.

****December 1, 2022